In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Tjasa Furlan
Tjasa Furlan Tjasa Furlan

Trbovlje General Hospital, Trbovlje (Slovenia)

Specialities : Chronic Heart Failure , Acute Heart Failure

7 presentations from this speaker

Impact of sacubitril/valsartan on left ventricular ejection fraction in patients with heart failure

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePosters
  • Speaker : T Furlan (Trbovlje,SI)

Influence of parenteral iron supplementation on handgrip strength

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePosters
  • Speaker : T Furlan (Trbovlje,SI)

Treatment of advanced heart failure with hemodialysis: hospital readmission rate and long-term outcome

Event : HFA Discoveries 2020

  • Session : HFA Discoveries - ePosters
  • Speaker : T Furlan (Trbovlje,SI)

Prognostic value of handgrip strength in patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : T Furlan (Trbovlje,SI)

Mid-ventricular Takotsubo cardiomyopathy caused by myasthenic crisis

Event : Heart Failure 2018

  • Session : Clinical Case Corner 4 - The great fire: inflammation of the heart and beyond
  • Speaker : T Furlan (Trbovlje,SI)

Reproducibility of 6-minute walk test in hemodialysed heart failure patients

Event : Heart Failure 2016

  • Session : Exercise testing & training
  • Speaker : T Furlan (Trbovlje,SI)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are